April 1, 2021
Johnson and Johnson announces issues with vaccine supplier
Johnson & Johnson announced that a batch of partially-completed coronavirus vaccines made by Emergent Biosolutions did not meet quality standards. The doses (reportedly in the range of ~15M) did not reach the fill-and-finish stage of production, and J&J noted that it remains on track to deliver 100M doses by the end of May. Here’s the full statement.